Pure Global

Aspartate Aminotransferase Quantitative Testing Drug - Vietnam Registration 220002866/PCBB-HCM

Access comprehensive regulatory information for Aspartate Aminotransferase Quantitative Testing Drug in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loแบกi B medical device is registered under number 220002866/PCBB-HCM and manufactured by Roche Diagnostics GmbH.

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Abbott Ireland Diagnostics Division, and 1 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
1 Competitors
1 Recent Registrations
220002866/PCBB-HCM
Registration Details
Vietnam MOH Registration: 220002866/PCBB-HCM
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Aspartate Aminotransferase Quantitative Testing Drug
VN: Thuแป‘c thแปญ xรฉt nghiแป‡m ฤ‘แป‹nh lฦฐแปฃng aspartate aminotransferase
Risk Class TTBYT Loแบกi B

Registration Details

220002866/PCBB-HCM

000.00.19.H29-220830-0004

ASTL

04657543190

Company Information

Technical Details

In vitro testing to quantify aspartate aminotransferase, with or without pyridoxal phosphate activation, in human serum and plasma on the cobas 111 system.

Dates and Status

Sep 05, 2022

Companies Making Similar Products
Companies providing products similar to "Aspartate Aminotransferase Quantitative Testing Drug"